Evidence map›Paper›PMID 38035682›Full record

ArticleBMJ case reports2023

Unusual case of sodium valproate-induced hyperammonaemia encephalopathy.

Shristhi Ranjith, Hesitha Abeysundera, Hilary Jeyaranjan

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.6field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Shristhi RanjithPsychiatry, Gold Coast University Hospital, Southport, Queensland, Australia.
Hesitha AbeysunderaPsychiatry, Gold Coast University Hospital, Southport, Queensland, Australia drhesitha@hotmail.com.ORCID http://orcid.org/0000-0001-7633-7601
Hilary JeyaranjanPsychiatry, Gold Coast University Hospital, Southport, Queensland, Australia.
Gold Coast Hospital · AUGriffith University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is limited information about sodium valproate-induced hyperammonaemia encephalopathy (VPAIHE). The aim of this case report is to provide medical practitioners with a greater awareness of the possible development of hyperammonaemia due to sodium valproate use and its associated complications.This paper describes a middle-aged man with a history of bipolar affective disorder who was admitted with a manic relapse secondary to medication non-compliance. His admission was complicated by an intensive care unit admission to manage medical compromise in the context of sodium VPAIHE.

Indexed as

Bipolar DisorderBrain DiseasesHyperammonemiaHumansMaleMiddle AgedNeoplasm Recurrence, LocalValproic AcidValproic AcidDrug interactionsMedical educationMedical managementPsychiatry (drugs and medicines)

Identifiers

PMID38035682
PMCPMC10689361
OpenAlexW4389210783

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.